Recent Quotes
My Watchlist
Indicators
Local Stocks
Local Stocks
Energy Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Biogen, Inc. (NQ: BIIB )

272.88 USD -4.38 (-1.58%)
Official Closing Price Updated: 7:58 PM EST, Feb 26, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Biogen, Inc.

< Previous 1 2
...
93 94 95 96 97 98 99 100 Next >
BRIEF-Biogen, Sobi to present long-term data on hemophilia drugs at conference
* Biogen and Sobi to showcase long-term efficacy and safety data from extended half-life hemophilia therapies at world federation of hemophilia 2016 world congress Source text for Eikon: Further... 
Tags companyNews
From Reuters: Company News
Biogen, Sobi to Report Long-Term Efficacy, Safety Data from A-LONG, ASPIRE, B-Long, B-YOND Trials at World Federation of Hemophilia World Congress
Biogen (NASDAQ: BIIB) and Swedish Orphan Biovitrum AB (publ) (Sobi™) (STO:SOBI) will present updated data on long-term safety and ... 
Tags Press Releases News BIIB
From Benzinga
BRIEF-Biogen SB5 accepted for review by European Medicines Agency
* Sb5, an adalimumab biosimilar referencing humira, accepted for review by european medicines agency Further company coverage: (Bengaluru Newsroom +91 80 6749-1130; within U.S. +1 646 223 8780) 
Tags companyNews
From Reuters: Company News
UPDATE 1-Samsung Bioepis seeks Europe approval for its Humira copy
* European Medicines Agency reviewing Samsung Bioepis' application 
Tags companyNews
From Reuters: Company News
Notable Friday Option Activity: TAP, BIIB, GILD
Among the underlying components of the S&P 500 index, we saw noteworthy options trading volume today in Molson Coors Brewing Co. (TAP), where a total of 7,842 contracts have traded so far, representing... 
Tags Stocks
From Market News Video
Agree To Buy Biogen At $135, Earn 3.5% Using Options
Investors considering a purchase of Biogen Inc (BIIB) stock, but tentative about paying the going market price of $258.29/share, might benefit from considering selling puts among the alternative... 
Tags Stocks
From Market News Video
QLD, CELG, PCLN, BIIB: Large Outflows Detected at ETF
Symbols mentioned in this story: QLD, CELG, PCLN, BIIB Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These... 
Tags ETFs
From ETF Channel
Sum Up The Pieces: RYH Could Be Worth $175
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Four high-quality biotech companies trading like risky startups
Ignore the gloom and doom about biotech stocks and consider companies with the best drug pipelines, says Michael Brush. 
Tags Company Announcements/Warnings AGIO Personal Finance
From MarketWatch
Morning Call For July 6, 2016
Sep E-mini S&Ps (ESU16 -0.61%) are down -0.67% and European stocks are down sharply by -2.09% on concern the fallout from Brexit will slow global economic growth. 
Tags Commodities Energy Bonds
From Blogs - TalkMarkets
Biogen And AbbVie's Once-Monthly ZINBRYTA Gets European Union Approval For Multiple Sclerosis Treatment
Biogen (NASDAQ: BIIB) and AbbVie (NYSE: ABBV) disclosed Tuesday that the European Commission (EC) has granted marketing authorization ... 
Tags Benzinga ABBV Biotech
From Benzinga
BRIEF-Biogen and AbbVie's drug approved in EU
* Biogen and AbbVie's once-monthly zinbryta(tm) (daclizumab) approved in European Union for treatment of multiple sclerosis 
Tags companyNews
From Reuters: Company News
BRIEF-Biogen and Abbvie's multiple sclerosis drug approved in EU
* Biogen and Abbvie's once-monthly Zinbryta (Daclizumab) approved in European Union for treatment of multiple sclerosis Source text for Eikon: Further company coverage: 
Tags companyNews
From Reuters: Company News
Large Cap Biopharmaceuticals-Valuation Models 2016
The biotech sector has underperformed the market because of the severe correction in August/September of 2015 followed by another downdraft in January 2016 all the result of “bubble” valuations. 
Tags Stocks / Equities Pharma/Biotech ETF's
From Blogs - TalkMarkets
BRexit Bottom For Biotech Creates Buying Opportunity
Biotech stocks soared yesterday getting relief from the brutal BRexit bashing that scared away all buyers. BRexit has little to do with biopharma but the”risk-off” pall brings caution and a move to... 
Tags Healthcare ETF's Pharma/Biotech
From Blogs - TalkMarkets
Biogen Optionality Looking Attractive; Bernstein Initiates At Outperform
Biogen Inc (NASDAQ: BIIB) has an aging MS franchise, but a solid biosimilar pipeline is sure to offset the loss of Tecfidera, Avonex and ... 
Tags Initiation Aaron Gal gilenya
From Benzinga
Stiff Biosimilar Headwinds To Negatively Impact Amgen's Aging Drug Portfolio
Bernstein's Aaron Gal initiated Amgen, Inc. (NASDAQ: AMGN) at Market Perform and set a price target of $161. The company will have a ... 
Tags Neupogen Analyst Color Epogen
From Benzinga
The Market In 5 Minutes: Swoosh And A Miss
Below is a tool used by the Benzinga News Desk each trading day -- it's a look at everything happening in the market, in five ... 
Tags WMB WMT NFLX
From Benzinga
Three ways to profit as investors panic about Brexit
The bottom line is that Britain’s vote won’t harm the U.S. economy, says Michael Brush. 
Tags VIXY Bond Market Personal Finance
From MarketWatch
The iShares NASDAQ Biotechnology Index (IBB): Biotech Stocks Are Pushing for Recovery
 
Tags NASDAQ:IBB NASDAQ:GILD NASDAQ:AMGN
From InvestorPlace
3 Stocks That Can and Should Start Paying Dividends
 
Tags Hot Stocks NASDAQ:FB NASDAQ:GOOGL
From InvestorPlace
Is Biogen Becoming A Reasonable Target For Acquisition? Baird Says So
Baird's Brian Skorney reiterated Biogen Inc (NASDAQ: BIIB)'s Neutral rating with a $268 price target. The reiteration came after ... 
Tags Brian Skorney BAN2401 BIIB
From Benzinga
Biotech ETFs Reeling in Longest Sector Selloff in Two Decades
Biotechnology-related exchange traded funds are stuck in a malaise, with the underlying biotech sector declining for the ninth consecutive session, its longest selloff in a twenty years. Since June 6,... 
Tags Lead Sector ETFs IBB
From ETF Trends
Stocks Hitting 52-Week Lows
HollyFrontier Corp (NYSE: HFC) shares dropped 1.98 percent to touch a new 52-week low of $23.74. HollyFrontier shares ... 
Tags PBF BIIB Intraday Update
From Benzinga
3 Biotech Stocks to Buy Now: CELG, REGN and BIIB
 
Tags NASDAQ:BIIB Trading Advice NASDAQ:CELG
From InvestorPlace
Biotech stocks are in for more election trouble on drug pricing
Hillary Clinton and Donald Trump have vowed to take action, writes Michael Brush. 
Tags ANTM Commodities SNY
From MarketWatch
Biogen And Gilead Sciences Buck Biotech Short Interest Trend
Short interest in many of the leading biotech stocks shrank in the most recent period. Two stocks in particular stood out among the ... 
Tags Benzinga Health Care Alexion Pharmaceuticals
From Benzinga
Biotech Rally Fizzles As Global Healthcare Issues Weigh…Update-1
The strong biotech rally fizzled early this week as longer term healthcare issues weighed on investors. High expectations from breakthrough products were tempered by the lingering long term concerns of... 
Tags Pharma/Biotech Stocks / Equities
From Blogs - TalkMarkets
5 Biotech Takeover Targets That Could Get Bought Soon
Don’t let the resurgence in M&A in the biotech sector pass you by. Bret Jensen shares his top five picks for likely acquisition targets in biotech. 
Tags Stocks / Equities Healthcare
From Blogs - TalkMarkets
5 Attractive Biotechnology Stocks For Healthy Long-term Returns
The biotechnology sector contains many exciting growth stocks.Consequently, I offer the following 5 biotechnology stocks as attractive looking research candidates primarily for growth or long-term... 
Tags Healthcare Stocks / Equities
From Blogs - TalkMarkets
< Previous 1 2
...
93 94 95 96 97 98 99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.